{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T10:12:55Z","timestamp":1783937575797,"version":"3.55.0"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.yebeh.2023.109363","type":"journal-article","created":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T15:55:31Z","timestamp":1690300531000},"page":"109363","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Update current understanding of neurometabolic disorders related to lysine metabolism"],"prefix":"10.1016","volume":"146","author":[{"given":"Fu-Man","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2023.109363_b0005","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/jimd.12076","article-title":"New insights into human lysine degradation pathways with relevance to pyridoxine-dependent epilepsy due to antiquitin deficiency","volume":"42","author":"Crowther","year":"2019","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.yebeh.2023.109363_b0010","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ymgme.2020.07.010","article-title":"The lysine degradation pathway: Subcellular compartmentalization and enzyme deficiencies","volume":"131","author":"Leandro","year":"2020","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.yebeh.2023.109363_b0015","doi-asserted-by":"crossref","first-page":"2556S","DOI":"10.1093\/jn\/nxaa112","article-title":"Inherited disorders of lysine metabolism: a review","volume":"150","author":"Bouchereau","year":"2020","journal-title":"J Nutr"},{"key":"10.1016\/j.yebeh.2023.109363_b0020","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1007\/s00726-013-1590-1","article-title":"Lysine metabolism in mammalian brain: an update on the importance of recent discoveries","volume":"45","author":"Hallen","year":"2013","journal-title":"Amino Acids"},{"key":"10.1016\/j.yebeh.2023.109363_b0025","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0006-291X(76)80288-4","article-title":"Pipecolic acid pathway: the major lysine metabolic route in the rat brain","volume":"69","author":"Chang","year":"1976","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.yebeh.2023.109363_b0030","first-page":"121","article-title":"Mouse lysine catabolism to aminoadipate occurs primarily through the saccharopine pathway; implications for pyridoxine dependent epilepsy (PDE)","volume":"2017","author":"Pena","year":"1863","journal-title":"Biochim Biophys Acta (BBA)-Mol Basis Dis"},{"key":"10.1016\/j.yebeh.2023.109363_b0035","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1002\/jimd.12276","article-title":"Deletion of 2-aminoadipic semialdehyde synthase limits metabolite accumulation in cell and mouse models for glutaric aciduria type 1","volume":"43","author":"Leandro","year":"2020","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.yebeh.2023.109363_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1172-8-57","article-title":"Genetic basis of hyperlysinemia","volume":"8","author":"Houten","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.yebeh.2023.109363_b0045","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.ajhg.2012.10.006","article-title":"DHTKD1 mutations cause 2-aminoadipic and 2-oxoadipic aciduria","volume":"91","author":"Danhauser","year":"2012","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.yebeh.2023.109363_b0050","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/8904_2017_49","article-title":"Glutaric aciduria type 3: three unrelated canadian cases, with different routes of ascertainment","volume":"39","author":"Waters","year":"2018","journal-title":"JIMD Reports"},{"key":"10.1016\/j.yebeh.2023.109363_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmg.2020.104032","article-title":"Glutaric aciduria type 1: genetic and phenotypic spectrum in 53 patients","volume":"63","author":"G\u00fcrb\u00fcz","year":"2020","journal-title":"Eur J Med Genet"},{"key":"10.1016\/j.yebeh.2023.109363_b0060","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ymgme.2010.11.159","article-title":"Clinical and molecular investigation of 19 Japanese cases of glutaric acidemia type 1","volume":"102","author":"Mushimoto","year":"2011","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.yebeh.2023.109363_b0065","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ejpn.2006.11.006","article-title":"Glutaric aciduria type 1: clinical, biochemical and molecular findings in patients from Israel","volume":"11","author":"Korman","year":"2007","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.yebeh.2023.109363_b0070","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1023\/A:1005683222187","article-title":"Sensitivity and specificity of free and total glutaric acid and 3-hydroxyglutaric acid measurements by stable-isotope dilution assays for the diagnosis of glutaric aciduria type I","volume":"22","author":"Baric","year":"1999","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.yebeh.2023.109363_b0075","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1023\/B:BOLI.0000045770.93429.3c","article-title":"Correlation of genotype and phenotype in glutaryl-CoA dehydrogenase deficiency","volume":"27","author":"Christensen","year":"2004","journal-title":"J Inherit Metab Dis"},{"issue":"46","key":"10.1016\/j.yebeh.2023.109363_b0080","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/jimd.12608","article-title":"Exploring genotype\u2013phenotype correlations in glutaric aciduria type","volume":"1","author":"Schuurmans","year":"2023","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.yebeh.2023.109363_b0085","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/j.1471-4159.2006.03813.x","article-title":"Intracerebral accumulation of glutaric and 3-hydroxyglutaric acids secondary to limited flux across the blood\u2013brain barrier constitute a biochemical risk factor for neurodegeneration in glutaryl-CoA dehydrogenase deficiency","volume":"97","author":"Sauer","year":"2006","journal-title":"J Neurochem"},{"key":"10.1016\/j.yebeh.2023.109363_b0090","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/brain\/awh401","article-title":"Neuropathological, biochemical and molecular findings in a glutaric acidemia type 1 cohort","volume":"128","author":"Funk","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2023.109363_b0095","doi-asserted-by":"crossref","first-page":"21830","DOI":"10.1074\/jbc.M502845200","article-title":"Bioenergetics in glutaryl-coenzyme A dehydrogenase deficiency: a role for glutaryl-coenzyme A","volume":"280","author":"Sauer","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.yebeh.2023.109363_b0100","doi-asserted-by":"crossref","first-page":"17777","DOI":"10.1074\/jbc.M111.232744","article-title":"Glutaric aciduria type 1 metabolites impair the succinate transport from astrocytic to neuronal cells","volume":"286","author":"Lamp","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.yebeh.2023.109363_b0105","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1203\/01.pdr.0000197313.44265.cb","article-title":"Endothelial effects of 3-hydroxyglutaric acid: implications for glutaric aciduria type I","volume":"59","author":"M\u00fchlhausen","year":"2006","journal-title":"Pediatr Res"},{"key":"10.1016\/j.yebeh.2023.109363_b0110","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ijdevneu.2019.05.005","article-title":"Pathogenesis of brain damage in glutaric acidemia type I: Lessons from the genetic mice model","volume":"78","author":"Wajner","year":"2019","journal-title":"Int J Dev Neurosci"},{"key":"10.1016\/j.yebeh.2023.109363_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2051-5960-2-13","article-title":"Mechanism of metabolic stroke and spontaneous cerebral hemorrhage in glutaric aciduria type I","volume":"2","author":"Zinnanti","year":"2014","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.yebeh.2023.109363_b0120","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/brain\/awp297","article-title":"Cerebral haemodynamics in patients with glutaryl-coenzyme A dehydrogenase deficiency","volume":"133","author":"Strauss","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2023.109363_b0125","doi-asserted-by":"crossref","first-page":"4504","DOI":"10.1093\/hmg\/ddv175","article-title":"Striatal neuronal death mediated by astrocytes from the Gcdh\u2212\/\u2212 mouse model of glutaric acidemia type I","volume":"24","author":"Olivera-Bravo","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.yebeh.2023.109363_b0130","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/brain\/awl009","article-title":"A diet-induced mouse model for glutaric aciduria type I","volume":"129","author":"Zinnanti","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2023.109363_b0135","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/jimd.12254","article-title":"Organic acidurias: Major gaps, new challenges, and a yet unfulfilled promise","volume":"44","author":"Dimitrov","year":"2021","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.yebeh.2023.109363_b0140","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/jimd.12033","article-title":"Patterns, evolution, and severity of striatal injury in insidious-vs acute-onset glutaric aciduria type 1","volume":"42","author":"Boy","year":"2019","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.yebeh.2023.109363_b0145","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1067\/mpd.2000.108954","article-title":"Age at symptom onset predicts severity of motor impairment and clinical outcome of glutaric acidemia type 1","volume":"137","author":"Bjugstad","year":"2000","journal-title":"J Pediatr"},{"key":"10.1016\/j.yebeh.2023.109363_b0150","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/BF01245343","article-title":"L-glutamate and L-aspartate concentrations in the developing and aging human putamen tissue","volume":"93","author":"Kornhuber","year":"1993","journal-title":"J Neural Trans\/Gen Sect JNT"},{"key":"10.1016\/j.yebeh.2023.109363_b0155","doi-asserted-by":"crossref","first-page":"065","DOI":"10.1055\/s-0040-1709704","article-title":"Glutaric Aciduria Type 1: a case report and review of literature","volume":"10","author":"Sanju","year":"2021","journal-title":"J Pediatr Intens Care"},{"key":"10.1016\/j.yebeh.2023.109363_b0160","article-title":"Recommendations for diagnosing and managing individuals with glutaric aciduria type 1: Third revision","author":"Boy","year":"2022","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.yebeh.2023.109363_b0165","doi-asserted-by":"crossref","first-page":"19300","DOI":"10.1038\/s41598-021-98809-9","article-title":"The biochemical subtype is a predictor for cognitive function in glutaric aciduria type 1: a national prospective follow-up study","volume":"11","author":"M\u00e4rtner","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.yebeh.2023.109363_b0170","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10048-015-0456-y","article-title":"Adult-onset glutaric aciduria type I presenting with white matter abnormalities and subependymal nodules","volume":"16","author":"Pierson","year":"2015","journal-title":"Neurogenetics"},{"key":"10.1016\/j.yebeh.2023.109363_b0175","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10048-020-00610-9","article-title":"Adult-onset glutaric aciduria type I: rare presentation of a treatable disorder","volume":"21","author":"Gelener","year":"2020","journal-title":"Neurogenetics"},{"key":"10.1016\/j.yebeh.2023.109363_b0180","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1212\/WNL.0b013e3182a2cbf2","article-title":"Subependymal mass lesions and peripheral polyneuropathy in adult-onset glutaric aciduria type I","volume":"81","author":"Herskovitz","year":"2013","journal-title":"Neurology"},{"issue":"134","key":"10.1016\/j.yebeh.2023.109363_b0185","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/brain\/awq269","article-title":"Therapeutic modulation of cerebral L-lysine metabolism in a mouse model for glutaric aciduria type","volume":"I","author":"Sauer","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2023.109363_b0190","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ymgme.2021.03.017","article-title":"The first knock-in rat model for glutaric aciduria type I allows further insights into pathophysiology in brain and periphery","volume":"133","author":"Melo","year":"2021","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.yebeh.2023.109363_b0195","doi-asserted-by":"crossref","first-page":"10021","DOI":"10.1002\/jcb.27332","article-title":"Oxidative damage in glutaric aciduria type I patients and the protective effects of l-carnitine treatment","volume":"119","author":"Guerreiro","year":"2018","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.yebeh.2023.109363_b0200","series-title":"American Journal of Medical Genetics Part C: Seminars in Medical Genetics","first-page":"38","article-title":"Type I glutaric aciduria, part 1: natural history of 77 patients","author":"Strauss","year":"2003"},{"key":"10.1016\/j.yebeh.2023.109363_b0205","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ymgme.2020.09.007","article-title":"Glutaric acidemia type 1: treatment and outcome of 168 patients over three decades","volume":"131","author":"Strauss","year":"2020","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.yebeh.2023.109363_b0210","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0929-6646(08)60127-8","article-title":"Early detection of glutaric aciduria type I by newborn screening in Taiwan","volume":"107","author":"Hsieh","year":"2008","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.yebeh.2023.109363_b0215","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jcma.2016.07.006","article-title":"Experiences during newborn screening for glutaric aciduria type 1: diagnosis, treatment, genotype, phenotype, and outcomes","volume":"80","author":"Tsai","year":"2017","journal-title":"J Chin Med Assoc"},{"key":"10.1016\/j.yebeh.2023.109363_b0220","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.ejpn.2013.01.003","article-title":"Glutaric aciduria type I: outcome of patients with early-versus late-diagnosis","volume":"17","author":"Couce","year":"2013","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.yebeh.2023.109363_b0225","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41436-020-00971-4","article-title":"Impact of newborn screening and quality of therapy on the neurological outcome in glutaric aciduria type 1: a meta-analysis","volume":"23","author":"Boy","year":"2021","journal-title":"Genet Med"},{"key":"10.1016\/j.yebeh.2023.109363_b0230","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adf4086","article-title":"Rescue of glutaric aciduria type I in mice by liver-directed therapies","volume":"15","author":"Barzi","year":"2023","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.yebeh.2023.109363_b0235","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/jimd.12045","article-title":"The genotypic spectrum of ALDH7A1 mutations resulting in pyridoxine dependent epilepsy: a common epileptic encephalopathy","volume":"42","author":"Coughlin","year":"2019","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.yebeh.2023.109363_b0240","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1136\/adc.2005.075069","article-title":"Epidemiology of pyridoxine dependent seizures in the Netherlands","volume":"90","author":"Been","year":"2005","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.yebeh.2023.109363_b0245","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/jimd.12332","article-title":"Consensus guidelines for the diagnosis and management of pyridoxine-dependent epilepsy due to \u03b1-aminoadipic semialdehyde dehydrogenase deficiency","volume":"44","author":"Coughlin","year":"2021","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.yebeh.2023.109363_b0250","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/ana.21568","article-title":"Folinic acid\u2013responsive seizures are identical to pyridoxine-dependent epilepsy","volume":"65","author":"Gallagher","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1016\/j.yebeh.2023.109363_b0255","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3390\/brainsci12010065","article-title":"Pyridoxine-dependent epilepsy and antiquitin deficiency resulting in neonatal-onset refractory seizures","volume":"12","author":"Kamini\u00f3w","year":"2021","journal-title":"Brain Sci"},{"key":"10.1016\/j.yebeh.2023.109363_b0260","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1534\/genetics.117.300137","article-title":"Pyridoxine-dependent epilepsy in zebrafish caused by Aldh7a1 deficiency","volume":"207","author":"Pena","year":"2017","journal-title":"Genetics"},{"key":"10.1016\/j.yebeh.2023.109363_b0265","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/17446651.2017.1273107","article-title":"Current knowledge for pyridoxine-dependent epilepsy: a 2016 update","volume":"12","author":"Pena","year":"2017","journal-title":"Expert Rev Endocrinol Metab"},{"key":"10.1016\/j.yebeh.2023.109363_b0270","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/jimd.12060","article-title":"Disorders affecting vitamin B6 metabolism","volume":"42","author":"Wilson","year":"2019","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.yebeh.2023.109363_b0275","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0257073","article-title":"Is impaired energy production a novel insight into the pathogenesis of pyridoxine-dependent epilepsy due to biallelic variants in ALDH7A1?","volume":"16","author":"Minenkova","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.yebeh.2023.109363_b0280","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/ana.24027","article-title":"Glial localization of antiquitin: implications for pyridoxine-dependent epilepsy","volume":"75","author":"Jansen","year":"2014","journal-title":"Ann Neurol"},{"key":"10.1016\/j.yebeh.2023.109363_b0285","doi-asserted-by":"crossref","first-page":"18452","DOI":"10.1074\/jbc.M109.077925","article-title":"Aldehyde dehydrogenase 7A1 (ALDH7A1) is a novel enzyme involved in cellular defense against hyperosmotic stress","volume":"285","author":"Brocker","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.yebeh.2023.109363_b0290","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/jimd.12569","article-title":"Metabolomics analysis of antiquitin deficiency in cultured human cells and plasma: Relevance to pyridoxine-dependent epilepsy","volume":"46","author":"Crowther","year":"2023","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.yebeh.2023.109363_b0295","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ymgme.2011.05.014","article-title":"Pyridoxine dependent epilepsy and antiquitin deficiency: clinical and molecular characteristics and recommendations for diagnosis, treatment and follow-up","volume":"104","author":"Stockler","year":"2011","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.yebeh.2023.109363_b0300","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/j.1469-8749.2012.04347.x","article-title":"Long-term outcome in pyridoxine-dependent epilepsy","volume":"54","author":"Bok","year":"2012","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.yebeh.2023.109363_b0305","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s00431-008-0823-x","article-title":"Clinical features and the management of pyridoxine-dependent and pyridoxine-responsive seizures: review of 63 North American cases submitted to a patient registry","volume":"168","author":"Basura","year":"2009","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.yebeh.2023.109363_b0310","unstructured":"Gospe Jr SM. Pyridoxine-dependent epilepsy\u2013ALDH7A1; 2021."},{"key":"10.1016\/j.yebeh.2023.109363_b0315","first-page":"65","article-title":"Clinical and genetic analysis of three Korean children with pyridoxine-dependent epilepsy","volume":"42","author":"Nam","year":"2012","journal-title":"Ann Clin Lab Sci"},{"key":"10.1016\/j.yebeh.2023.109363_b0320","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/epi.16408","article-title":"Diagnosis of pyridoxine-dependent epilepsy in an adult presenting with recurrent status epilepticus","volume":"61","author":"Osman","year":"2020","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2023.109363_b0325","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.pediatrneurol.2015.12.013","article-title":"Pyridoxine-dependent epilepsy: an expanding clinical spectrum","volume":"59","author":"van Karnebeek","year":"2016","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.yebeh.2023.109363_b0330","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.braindev.2020.02.005","article-title":"Electroclinical variability of pyridoxine-dependent epilepsy caused by ALDH7A1 gene mutations in four Taiwanese children","volume":"42","author":"Lee","year":"2020","journal-title":"Brain Dev"},{"key":"10.1016\/j.yebeh.2023.109363_b0335","article-title":"The spectrum of pyridoxine dependent epilepsy across the age span: a nationwide retrospective observational study","author":"Jamali","year":"2023","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2023.109363_b0340","doi-asserted-by":"crossref","first-page":"e1092","DOI":"10.1542\/peds.2013-1230","article-title":"Fetal onset ventriculomegaly and subependymal cysts in a pyridoxine dependent epilepsy patient","volume":"133","author":"Jain-Ghai","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.yebeh.2023.109363_b0345","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s10545-010-9187-2","article-title":"The genotypic and phenotypic spectrum of pyridoxine-dependent epilepsy due to mutations in ALDH7A1","volume":"33","author":"Scharer","year":"2010","journal-title":"J Inher Metabol Disease: J Soc Study Inborn Errors Metabol"},{"key":"10.1016\/j.yebeh.2023.109363_b0350","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ymgme.2012.09.006","article-title":"Lysine restricted diet for pyridoxine-dependent epilepsy: first evidence and future trials","volume":"107","author":"van Karnebeek","year":"2012","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.yebeh.2023.109363_b0355","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.ejpn.2014.07.001","article-title":"Novel therapy for pyridoxine dependent epilepsy due to ALDH7A1 genetic defect: L-arginine supplementation alternative to lysine-restricted diet","volume":"18","author":"Mercimek-Mahmutoglu","year":"2014","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.yebeh.2023.109363_b0360","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ymgme.2015.05.011","article-title":"Triple therapy with pyridoxine, arginine supplementation and dietary lysine restriction in pyridoxine-dependent epilepsy: neurodevelopmental outcome","volume":"116","author":"Coughlin","year":"2015","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.yebeh.2023.109363_b0365","first-page":"47","article-title":"Lysine-restricted diet as adjunct therapy for pyridoxine-dependent epilepsy: the PDE consortium consensus recommendations","volume":"15","author":"van Karnebeek","year":"2015","journal-title":"JIMD Rep"},{"key":"10.1016\/j.yebeh.2023.109363_b0370","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.ymgme.2022.02.005","article-title":"Timing of therapy and neurodevelopmental outcomes in 18 families with pyridoxine-dependent epilepsy","volume":"135","author":"Tseng","year":"2022","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.yebeh.2023.109363_b0375","doi-asserted-by":"crossref","first-page":"e2627","DOI":"10.1212\/WNL.0000000000201222","article-title":"Association between lysine reduction therapies and cognitive outcomes in patients with pyridoxine-dependent epilepsy","volume":"99","author":"Coughlin","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2023.109363_b0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.ab.2020.113739","article-title":"Identification of new biomarkers of pyridoxine-dependent epilepsy by GC\/MS-based urine metabolomics","volume":"604","author":"Kuhara","year":"2020","journal-title":"Anal Biochem"},{"key":"10.1016\/j.yebeh.2023.109363_b0385","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/jimd.12059","article-title":"Identification of a novel biomarker for pyridoxine-dependent epilepsy: implications for newborn screening","volume":"42","author":"Wempe","year":"2019","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.yebeh.2023.109363_b0390","doi-asserted-by":"crossref","DOI":"10.1172\/JCI148272","article-title":"Untargeted metabolomics and infrared ion spectroscopy identify biomarkers for pyridoxine-dependent epilepsy","volume":"131","author":"Engelke","year":"2021","journal-title":"J Clin Invest"},{"key":"10.1016\/j.yebeh.2023.109363_b0395","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1523\/JNEUROSCI.1459-21.2022","article-title":"The metabolite saccharopine impairs neuronal development by inhibiting the neurotrophic function of glucose-6-phosphate isomerase","volume":"42","author":"Guo","year":"2022","journal-title":"J Neurosci"},{"key":"10.1016\/j.yebeh.2023.109363_b0400","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ymgme.2013.06.021","article-title":"Clinical, biochemical, molecular and therapeutic aspects of 2 new cases of 2-aminoadipic semialdehyde synthase deficiency","volume":"110","author":"Tondo","year":"2013","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.yebeh.2023.109363_b0405","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s10545-015-9841-9","article-title":"Genetic basis of alpha-aminoadipic and alpha-ketoadipic aciduria","volume":"38","author":"Hagen","year":"2015","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.yebeh.2023.109363_b0410","first-page":"2220","article-title":"Elevated glutaric acid levels in Dhtkd1-\/Gcdh-double knockout mice challenge our current understanding of lysine metabolism","volume":"2017","author":"Biagosch","year":"1863","journal-title":"Biochim Biophys Acta (BBA)-Mol Basis Disease"},{"key":"10.1016\/j.yebeh.2023.109363_b0415","doi-asserted-by":"crossref","first-page":"8213","DOI":"10.3390\/ijms23158213","article-title":"Functional versatility of the human 2-oxoadipate dehydrogenase in the L-lysine degradation pathway toward its non-cognate substrate 2-oxopimelic acid","volume":"23","author":"Nemeria","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.yebeh.2023.109363_b0420","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1023\/A:1021207419125","article-title":"Glutaric aciduria type III: a distinctive non-disease?","volume":"25","author":"Knerr","year":"2002","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.yebeh.2023.109363_b0425","doi-asserted-by":"crossref","first-page":"657","DOI":"10.24953\/turkjped.2020.04.017","article-title":"Two patients with glutaric aciduria type 3: a novel mutation and brain magnetic resonance imaging findings","volume":"62","author":"Dorum","year":"2020","journal-title":"Turk J Pediatr"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505023002822?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505023002822?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:51:16Z","timestamp":1761504676000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505023002822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":85,"alternative-id":["S1525505023002822"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2023.109363","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Update current understanding of neurometabolic disorders related to lysine metabolism","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2023.109363","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109363"}}